{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:19:27Z","timestamp":1794028767967,"version":"4.8.0"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1038\/s41568-020-0251-4","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T12:02:54Z","timestamp":1585656174000},"page":"274-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":180,"title":["Understanding cachexia in the context of metastatic progression"],"prefix":"10.1038","volume":"20","author":[{"given":"Anup K.","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1922-6881","authenticated-orcid":false,"given":"Swarnali","family":"Acharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"251_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"251_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan, D. & Coussens, L. M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21, 309\u2013322 (2012).","journal-title":"Cancer Cell"},{"key":"251_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","volume":"16","author":"KC Fearon","year":"2012","unstructured":"Fearon, K. C., Glass, D. J. & Guttridge, D. C. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 16, 153\u2013166 (2012).","journal-title":"Cell Metab."},{"key":"251_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon, K., Arends, J. & Baracos, V. Understanding the mechanisms and treatment options in cancer cachexia. Nat. Rev. Clin. Oncol. 10, 90\u201399 (2013).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"251_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S1470-2045(00)00033-4","volume":"1","author":"E Bruera","year":"2000","unstructured":"Bruera, E. & Sweeney, C. Cachexia and asthenia in cancer patients. Lancet Oncol. 1, 138\u2013147 (2000).","journal-title":"Lancet Oncol."},{"key":"251_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s13539-013-0111-0","volume":"4","author":"K Kalantar-Zadeh","year":"2013","unstructured":"Kalantar-Zadeh, K. et al. Why cachexia kills: examining the causality of poor outcomes in wasting conditions. J. Cachexia Sarcopenia Muscle 4, 89\u201394 (2013).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"251_CR7","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos, V. E., Martin, L., Korc, M., Guttridge, D. C. & Fearon, K. C. H. Cancer-associated cachexia. Nat. Rev. Dis. Primers 4, 17105 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"251_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.canlet.2012.05.013","volume":"324","author":"X Ni","year":"2012","unstructured":"Ni, X., Yang, J. & Li, M. Imaging-guided curative surgical resection of pancreatic cancer in a xenograft mouse model. Cancer Lett. 324, 179\u2013185 (2012).","journal-title":"Cancer Lett."},{"key":"251_CR9","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1158\/1078-0432.CCR-11-2133","volume":"18","author":"IJ Gallagher","year":"2012","unstructured":"Gallagher, I. J. et al. Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies. Clin. Cancer Res. 18, 2817\u20132827 (2012).","journal-title":"Clin. Cancer Res."},{"key":"251_CR10","doi-asserted-by":"publisher","first-page":"18041","DOI":"10.1002\/jcp.28437","volume":"234","author":"A Salazar-Degracia","year":"2019","unstructured":"Salazar-Degracia, A. et al. Reduced lung cancer burden by selective immunomodulators elicits improvements in muscle proteolysis and strength in cachectic mice. J. Cell Physiol. 234, 18041\u201318052 (2019).","journal-title":"J. Cell Physiol."},{"key":"251_CR11","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41591-018-0054-2","volume":"24","author":"G Wang","year":"2018","unstructured":"Wang, G. et al. Metastatic cancers promote cachexia through ZIP14 upregulation in skeletal muscle. Nat. Med. 24, 770\u2013781 (2018).","journal-title":"Nat. Med."},{"key":"251_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41571-018-0134-8","volume":"16","author":"RL Anderson","year":"2019","unstructured":"Anderson, R. L. et al. A framework for the development of effective anti-metastatic agents. Nat. Rev. Clin. Oncol. 16, 185\u2013204 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"251_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.lungcan.2009.06.020","volume":"68","author":"A Jatoi","year":"2010","unstructured":"Jatoi, A. et al. A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and\/or poor performance non-small cell lung cancer patients (N01C9). Lung Cancer 68, 234\u2013239 (2010).","journal-title":"Lung Cancer"},{"key":"251_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.semcdb.2015.09.002","volume":"54","author":"F Penna","year":"2016","unstructured":"Penna, F., Busquets, S. & Argiles, J. M. Experimental cancer cachexia: evolving strategies for getting closer to the human scenario. Semin. Cell Dev. Biol. 54, 20\u201327 (2016).","journal-title":"Semin. Cell Dev. Biol."},{"key":"251_CR15","doi-asserted-by":"publisher","first-page":"43442","DOI":"10.18632\/oncotarget.9779","volume":"7","author":"R Barreto","year":"2016","unstructured":"Barreto, R. et al. Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1\/2 and p38 MAPKs. Oncotarget 7, 43442\u201343460 (2016).","journal-title":"Oncotarget"},{"key":"251_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/mus.21809","volume":"43","author":"LA Gilliam","year":"2011","unstructured":"Gilliam, L. A., Moylan, J. S., Callahan, L. A., Sumandea, M. P. & Reid, M. B. Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy. Muscle Nerve 43, 94\u2013102 (2011).","journal-title":"Muscle Nerve"},{"key":"251_CR17","doi-asserted-by":"publisher","first-page":"7590","DOI":"10.4081\/ejtm.2018.7590","volume":"28","author":"JS Damrauer","year":"2018","unstructured":"Damrauer, J. S. et al. Chemotherapy-induced muscle wasting: association with NF-\u03baB and cancer cachexia. Eur. J. Transl. Myol. 28, 7590 (2018).","journal-title":"Eur. J. Transl. Myol."},{"key":"251_CR18","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nm.3961","volume":"21","author":"DL Waning","year":"2015","unstructured":"Waning, D. L. et al. Excess TGF-\u03b2 mediates muscle weakness associated with bone metastases in mice. Nat. Med. 21, 1262\u20131271 (2015).","journal-title":"Nat. Med."},{"key":"251_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132786","volume":"10","author":"SH Greco","year":"2015","unstructured":"Greco, S. H. et al. TGF-\u03b2 blockade reduces mortality and metabolic changes in a validated murine model of pancreatic cancer cachexia. PLoS One 10, e0132786 (2015).","journal-title":"PLoS One"},{"key":"251_CR20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1097\/MPA.0000000000000843","volume":"46","author":"KL Go","year":"2017","unstructured":"Go, K. L. et al. Orthotopic patient-derived pancreatic cancer xenografts engraft into the pancreatic parenchyma, metastasize, and induce muscle wasting to recapitulate the human disease. Pancreas 46, 813\u2013819 (2017).","journal-title":"Pancreas"},{"key":"251_CR21","first-page":"5547","volume":"45","author":"JA Norton","year":"1985","unstructured":"Norton, J. A., Moley, J. F., Green, M. V., Carson, R. E. & Morrison, S. D. Parabiotic transfer of cancer anorexia\/cachexia in male rats. Cancer Res. 45, 5547\u20135552 (1985).","journal-title":"Cancer Res."},{"key":"251_CR22","doi-asserted-by":"publisher","first-page":"182872","DOI":"10.1155\/2015\/182872","volume":"2015","author":"JM Argiles","year":"2015","unstructured":"Argiles, J. M., Stemmler, B., Lopez-Soriano, F. J. & Busquets, S. Nonmuscle tissues contribution to cancer cachexia. Mediators Inflamm. 2015, 182872 (2015).","journal-title":"Mediators Inflamm."},{"key":"251_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nut.2019.03.012","volume":"66","author":"JM Argiles","year":"2019","unstructured":"Argiles, J. M., Lopez-Soriano, F. J. & Busquets, S. Mediators of cachexia in cancer patients. Nutrition 66, 11\u201315 (2019).","journal-title":"Nutrition"},{"key":"251_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1101\/gad.276733.115","volume":"30","author":"M Petruzzelli","year":"2016","unstructured":"Petruzzelli, M. & Wagner, E. F. Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes. Dev. 30, 489\u2013501 (2016).","journal-title":"Genes. Dev."},{"key":"251_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcdb.2015.11.002","volume":"54","author":"M Sandri","year":"2016","unstructured":"Sandri, M. Protein breakdown in cancer cachexia. Semin. Cell Dev. Biol. 54, 11\u201319 (2016).","journal-title":"Semin. Cell Dev. Biol."},{"key":"251_CR26","first-page":"E996","volume":"268","author":"VE Baracos","year":"1995","unstructured":"Baracos, V. E., DeVivo, C., Hoyle, D. H. & Goldberg, A. L. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am. J. Physiol. 268, E996\u2013E1006 (1995).","journal-title":"Am. J. Physiol."},{"key":"251_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","volume":"14","author":"TN Stitt","year":"2004","unstructured":"Stitt, T. N. et al. The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 14, 395\u2013403 (2004).","journal-title":"Mol. Cell"},{"key":"251_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","volume":"117","author":"M Sandri","year":"2004","unstructured":"Sandri, M. et al. FOXO transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399\u2013412 (2004).","journal-title":"Cell"},{"key":"251_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13539-011-0051-5","volume":"3","author":"MA Honors","year":"2012","unstructured":"Honors, M. A. & Kinzig, K. P. The role of insulin resistance in the development of muscle wasting during cancer cachexia. J. Cachexia Sarcopenia Muscle 3, 5\u201311 (2012).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"251_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/1097-0142(19850101)55:1+<225::AID-CNCR2820551304>3.0.CO;2-7","volume":"55","author":"D Heber","year":"1985","unstructured":"Heber, D., Byerly, L. O. & Chlebowski, R. T. Metabolic abnormalities in the cancer patient. Cancer 55, 225\u2013229 (1985).","journal-title":"Cancer"},{"key":"251_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1079\/PNS19720042","volume":"31","author":"GF Cahill Jr","year":"1972","unstructured":"Cahill, G. F. Jr, Aoki, T. T., Brennan, M. F. & Muller, W. A. Insulin and muscle amino acid balance. Proc. Nutr. Soc. 31, 233\u2013238 (1972).","journal-title":"Proc. Nutr. Soc."},{"key":"251_CR32","unstructured":"Voet, D. & Voet, J. G. Biochemistry. 4th edn (Wiley, 2011)."},{"key":"251_CR33","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1210\/en.2006-0251","volume":"147","author":"X Wang","year":"2006","unstructured":"Wang, X., Hu, Z., Hu, J., Du, J. & Mitch, W. E. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology 147, 4160\u20134168 (2006).","journal-title":"Endocrinology"},{"key":"251_CR34","first-page":"E1033","volume":"258","author":"LC Fernandes","year":"1990","unstructured":"Fernandes, L. C., Machado, U. F., Nogueira, C. R., Carpinelli, A. R. & Curi, R. Insulin secretion in Walker 256 tumor cachexia. Am. J. Physiol. 258, E1033\u2013E1036 (1990).","journal-title":"Am. J. Physiol."},{"key":"251_CR35","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ijc.24784","volume":"126","author":"ML Asp","year":"2010","unstructured":"Asp, M. L., Tian, M., Wendel, A. A. & Belury, M. A. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int. J. Cancer 126, 756\u2013763 (2010).","journal-title":"Int. J. Cancer"},{"key":"251_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.devcel.2015.02.012","volume":"33","author":"Y Kwon","year":"2015","unstructured":"Kwon, Y. et al. Systemic organ wasting induced by localized expression of the secreted insulin\/IGF antagonist ImpL2. Dev. Cell 33, 36\u201346 (2015).","journal-title":"Dev. Cell"},{"key":"251_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.devcel.2015.03.001","volume":"33","author":"A Figueroa-Clarevega","year":"2015","unstructured":"Figueroa-Clarevega, A. & Bilder, D. Malignant Drosophila tumors interrupt insulin signaling to induce cachexia-like wasting. Dev. Cell 33, 47\u201355 (2015).","journal-title":"Dev. Cell"},{"key":"251_CR38","doi-asserted-by":"publisher","first-page":"957","DOI":"10.4161\/cbt.12.11.18134","volume":"12","author":"ML Asp","year":"2011","unstructured":"Asp, M. L., Tian, M., Kliewer, K. L. & Belury, M. A. Rosiglitazone delayed weight loss and anorexia while attenuating adipose depletion in mice with cancer cachexia. Cancer Biol. Ther. 12, 957\u2013965 (2011).","journal-title":"Cancer Biol. Ther."},{"key":"251_CR39","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.nut.2013.12.005","volume":"30","author":"K Trobec","year":"2014","unstructured":"Trobec, K. et al. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia. Nutrition 30, 1069\u20131075 (2014).","journal-title":"Nutrition"},{"key":"251_CR40","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/jcp.22821","volume":"227","author":"S Bhatnagar","year":"2012","unstructured":"Bhatnagar, S., Mittal, A., Gupta, S. K. & Kumar, A. TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases. J. Cell Physiol. 227, 1042\u20131051 (2012).","journal-title":"J. Cell Physiol."},{"key":"251_CR41","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2004.09.027","volume":"119","author":"D Cai","year":"2004","unstructured":"Cai, D. et al. IKK\u03b2\/NF-\u03baB activation causes severe muscle wasting in mice. Cell 119, 285\u2013298 (2004).","journal-title":"Cell"},{"key":"251_CR42","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1126\/science.289.5488.2363","volume":"289","author":"DC Guttridge","year":"2000","unstructured":"Guttridge, D. C., Mayo, M. W., Madrid, L. V., Wang, C. Y. & Baldwin, A. S. Jr. NF-\u03baB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289, 2363\u20132366 (2000).","journal-title":"Science"},{"key":"251_CR43","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/nm.4093","volume":"22","author":"T Fukawa","year":"2016","unstructured":"Fukawa, T. et al. Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia. Nat. Med. 22, 666\u2013671 (2016).","journal-title":"Nat. Med."},{"key":"251_CR44","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1126\/science.1069525","volume":"296","author":"TA Zimmers","year":"2002","unstructured":"Zimmers, T. A. et al. Induction of cachexia in mice by systemically administered myostatin. Science 296, 1486\u20131488 (2002).","journal-title":"Science"},{"key":"251_CR45","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.bbrc.2009.12.123","volume":"391","author":"ME Benny Klimek","year":"2010","unstructured":"Benny Klimek, M. E. et al. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Biochem. Biophys. Res. Commun. 391, 1548\u20131554 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"251_CR46","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou, X. et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 142, 531\u2013543 (2010).","journal-title":"Cell"},{"key":"251_CR47","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm.4394","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang, L. et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat. Med. 23, 1158\u20131166 (2017).","journal-title":"Nat. Med."},{"key":"251_CR48","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/nm.4393","volume":"23","author":"PJ Emmerson","year":"2017","unstructured":"Emmerson, P. J. et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat. Med. 23, 1215\u20131219 (2017).","journal-title":"Nat. Med."},{"key":"251_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature24042","volume":"550","author":"JY Hsu","year":"2017","unstructured":"Hsu, J. Y. et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature 550, 255\u2013259 (2017).","journal-title":"Nature"},{"key":"251_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055174","volume":"8","author":"VW Tsai","year":"2013","unstructured":"Tsai, V. W. et al. TGF-\u03b2 superfamily cytokine MIC-1\/GDF15 is a physiological appetite and body weight regulator. PLoS One 8, e55174 (2013).","journal-title":"PLoS One"},{"key":"251_CR51","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/nm1677","volume":"13","author":"H Johnen","year":"2007","unstructured":"Johnen, H. et al. Tumor-induced anorexia and weight loss are mediated by the TGF-\u03b2 superfamily cytokine MIC-1. Nat. Med. 13, 1333\u20131340 (2007).","journal-title":"Nat. Med."},{"key":"251_CR52","doi-asserted-by":"publisher","first-page":"531","DOI":"10.15252\/emmm.201607231","volume":"9","author":"DW Hammers","year":"2017","unstructured":"Hammers, D. W. et al. Supraphysiological levels of GDF11 induce striated muscle atrophy. EMBO Mol. Med. 9, 531\u2013544 (2017).","journal-title":"EMBO Mol. Med."},{"key":"251_CR53","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00395-017-0639-9","volume":"112","author":"TA Zimmers","year":"2017","unstructured":"Zimmers, T. A. et al. Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting. Basic. Res. Cardiol. 112, 48 (2017).","journal-title":"Basic. Res. Cardiol."},{"key":"251_CR54","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.celrep.2018.01.044","volume":"22","author":"JE Jones","year":"2018","unstructured":"Jones, J. E. et al. Supraphysiologic administration of GDF11 induces cachexia in part by upregulating GDF15. Cell Rep. 22, 1522\u20131530 (2018).","journal-title":"Cell Rep."},{"key":"251_CR55","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.devcel.2019.04.011","volume":"49","author":"I Wortzel","year":"2019","unstructured":"Wortzel, I., Dror, S., Kenific, C. M. & Lyden, D. Exosome-mediated metastasis: communication from a distance. Dev. Cell 49, 347\u2013360 (2019).","journal-title":"Dev. Cell"},{"key":"251_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00726-x","volume":"8","author":"G Zhang","year":"2017","unstructured":"Zhang, G. et al. Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90. Nat. Commun. 8, 589 (2017).","journal-title":"Nat. Commun."},{"key":"251_CR57","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1053\/j.gastro.2018.10.026","volume":"156","author":"J Yang","year":"2019","unstructured":"Yang, J. et al. ZIP4 promotes muscle wasting and cachexia in mice with orthotopic pancreatic tumors by stimulating RAB27B-regulated release of extracellular vesicles from cancer cells. Gastroenterology 156, 722\u2013734 (2019).","journal-title":"Gastroenterology"},{"key":"251_CR58","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1073\/pnas.1402714111","volume":"111","author":"WA He","year":"2014","unstructured":"He, W. A. et al. Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc. Natl Acad. Sci. USA 111, 4525\u20134529 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"251_CR59","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1158\/0008-5472.CAN-17-3878","volume":"78","author":"F Calore","year":"2018","unstructured":"Calore, F. et al. The TLR7\/8\/9 antagonist IMO-8503 inhibits cancer-induced cachexia. Cancer Res. 78, 6680\u20136690 (2018).","journal-title":"Cancer Res."},{"key":"251_CR60","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1126\/science.1198973","volume":"333","author":"SK Das","year":"2011","unstructured":"Das, S. K. et al. Adipose triglyceride lipase contributes to cancer-associated cachexia. Science 333, 233\u2013238 (2011).","journal-title":"Science"},{"key":"251_CR61","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1210\/en.2013-1403","volume":"154","author":"M Giralt","year":"2013","unstructured":"Giralt, M. & Villarroya, F. White, brown, beige\/brite: different adipose cells for different functions? Endocrinology 154, 2992\u20133000 (2013).","journal-title":"Endocrinology"},{"key":"251_CR62","doi-asserted-by":"publisher","first-page":"886","DOI":"10.4161\/15384047.2014.987075","volume":"16","author":"KL Kliewer","year":"2015","unstructured":"Kliewer, K. L. et al. Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice. Cancer Biol. Ther. 16, 886\u2013897 (2015).","journal-title":"Cancer Biol. Ther."},{"key":"251_CR63","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","volume":"20","author":"M Petruzzelli","year":"2014","unstructured":"Petruzzelli, M. et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab. 20, 433\u2013447 (2014).","journal-title":"Cell Metab."},{"key":"251_CR64","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature13528","volume":"513","author":"S Kir","year":"2014","unstructured":"Kir, S. et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature 513, 100\u2013104 (2014).","journal-title":"Nature"},{"key":"251_CR65","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s12576-016-0472-1","volume":"67","author":"QY Ang","year":"2017","unstructured":"Ang, Q. Y. et al. A new method of infrared thermography for quantification of brown adipose tissue activation in healthy adults (TACTICAL): a randomized trial. J. Physiol. Sci. 67, 395\u2013406 (2017).","journal-title":"J. Physiol. Sci."},{"key":"251_CR66","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"251_CR67","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/jnci\/80.11.842","volume":"80","author":"W Mueller-Klieser","year":"1988","unstructured":"Mueller-Klieser, W., Walenta, S., Paschen, W., Kallinowski, F. & Vaupel, P. Metabolic imaging in microregions of tumors and normal tissues with bioluminescence and photon counting. J. Natl Cancer Inst. 80, 842\u2013848 (1988).","journal-title":"J. Natl Cancer Inst."},{"key":"251_CR68","first-page":"916","volume":"60","author":"S Walenta","year":"2000","unstructured":"Walenta, S. et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 60, 916\u2013921 (2000).","journal-title":"Cancer Res."},{"key":"251_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/s12976-015-0015-0","volume":"12","author":"DE Friesen","year":"2015","unstructured":"Friesen, D. E., Baracos, V. E. & Tuszynski, J. A. Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia. Theor. Biol. Med. Model. 12, 17 (2015).","journal-title":"Theor. Biol. Med. Model."},{"key":"251_CR70","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s13539-014-0154-x","volume":"5","author":"JM Argiles","year":"2014","unstructured":"Argiles, J. M., Fontes-Oliveira, C. C., Toledo, M., Lopez-Soriano, F. J. & Busquets, S. Cachexia: a problem of energetic inefficiency. J. Cachexia Sarcopenia Muscle 5, 279\u2013286 (2014).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"251_CR71","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1126\/science.167.3920.1003","volume":"167","author":"P Felig","year":"1970","unstructured":"Felig, P., Pozefsky, T., Marliss, E. & Cahill, G. F. Jr. Alanine: key role in gluconeogenesis. Science 167, 1003\u20131004 (1970).","journal-title":"Science"},{"key":"251_CR72","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0065-2571(76)90010-8","volume":"14","author":"E Ishikawa","year":"1976","unstructured":"Ishikawa, E. The regulation of uptake and output of amino acids by rat tissues. Adv. Enzyme Regul. 14, 117\u2013136 (1976).","journal-title":"Adv. Enzyme Regul."},{"key":"251_CR73","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1172\/JCI106771","volume":"50","author":"P Felig","year":"1971","unstructured":"Felig, P. & Wahren, J. Amino acid metabolism in exercising man. J. Clin. Invest. 50, 2703\u20132714 (1971).","journal-title":"J. Clin. Invest."},{"key":"251_CR74","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/SPC.0b013e3283186be2","volume":"2","author":"NA Stephens","year":"2008","unstructured":"Stephens, N. A., Skipworth, R. J. & Fearon, K. C. Cachexia, survival and the acute phase response. Curr. Opin. Support. Palliat. Care 2, 267\u2013274 (2008).","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"251_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022538","volume":"6","author":"A Bonetto","year":"2011","unstructured":"Bonetto, A. et al. STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One 6, e22538 (2011).","journal-title":"PLoS One"},{"key":"251_CR76","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1749-6632.1982.tb22124.x","volume":"389","author":"I Kushner","year":"1982","unstructured":"Kushner, I. The phenomenon of the acute phase response. Ann. NY Acad. Sci. 389, 39\u201348 (1982).","journal-title":"Ann. NY Acad. Sci."},{"key":"251_CR77","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/jn\/124.6.906","volume":"124","author":"PJ Reeds","year":"1994","unstructured":"Reeds, P. J., Fjeld, C. R. & Jahoor, F. Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states? J. Nutr. 124, 906\u2013910 (1994).","journal-title":"J. Nutr."},{"key":"251_CR78","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/jn\/128.8.1355","volume":"128","author":"T Preston","year":"1998","unstructured":"Preston, T. et al. Fibrinogen synthesis is elevated in fasting cancer patients with an acute phase response. J. Nutr. 128, 1355\u20131360 (1998).","journal-title":"J. Nutr."},{"key":"251_CR79","doi-asserted-by":"publisher","first-page":"E743","DOI":"10.1073\/pnas.1714703115","volume":"115","author":"MD Goncalves","year":"2018","unstructured":"Goncalves, M. D. et al. Fenofibrate prevents skeletal muscle loss in mice with lung cancer. Proc. Natl Acad. Sci. USA 115, E743\u2013E752 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"251_CR80","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.cmet.2016.10.010","volume":"24","author":"TR Flint","year":"2016","unstructured":"Flint, T. R. et al. Tumor-induced IL-6 reprograms host metabolism to suppress anti-tumor immunity. Cell Metab. 24, 672\u2013684 (2016).","journal-title":"Cell Metab."},{"key":"251_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JOE-07-0606","volume":"197","author":"O Schakman","year":"2008","unstructured":"Schakman, O., Gilson, H. & Thissen, J. P. Mechanisms of glucocorticoid-induced myopathy. J. Endocrinol. 197, 1\u201310 (2008).","journal-title":"J. Endocrinol."},{"key":"251_CR82","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2007.09.009","volume":"6","author":"BA Clarke","year":"2007","unstructured":"Clarke, B. A. et al. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab. 6, 376\u2013385 (2007).","journal-title":"Cell Metab."},{"key":"251_CR83","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.1096\/fj.13-230375","volume":"27","author":"TP Braun","year":"2013","unstructured":"Braun, T. P. et al. Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle. FASEB J. 27, 3572\u20133582 (2013).","journal-title":"FASEB J."},{"key":"251_CR84","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.043166","author":"JR Huot","year":"2020","unstructured":"Huot, J. R., Novinger, L. J., Pin, F. & Bonetto, A. HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia. Dis. Model. Mech. https:\/\/doi.org\/10.1242\/dmm.043166 (2020).","journal-title":"Dis. Model. Mech."},{"key":"251_CR85","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0092-8674(00)81280-5","volume":"84","author":"DA Lauffenburger","year":"1996","unstructured":"Lauffenburger, D. A. & Horwitz, A. F. Cell migration: a physically integrated molecular process. Cell 84, 359\u2013369 (1996).","journal-title":"Cell"},{"key":"251_CR86","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20, 69\u201384 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"251_CR87","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1074\/mcp.M113.029587","volume":"12","author":"K Rasanen","year":"2013","unstructured":"Rasanen, K. et al. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target. Mol. Cell Proteom. 12, 3778\u20133792 (2013).","journal-title":"Mol. Cell Proteom."},{"key":"251_CR88","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/path.4546","volume":"236","author":"M Suarez-Carmona","year":"2015","unstructured":"Suarez-Carmona, M. et al. Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment. J. Pathol. 236, 491\u2013504 (2015).","journal-title":"J. Pathol."},{"key":"251_CR89","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1158\/0008-5472.CAN-11-0156","volume":"71","author":"RI Fernando","year":"2011","unstructured":"Fernando, R. I., Castillo, M. D., Litzinger, M., Hamilton, D. H. & Palena, C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res. 71, 5296\u20135306 (2011).","journal-title":"Cancer Res."},{"key":"251_CR90","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ncb3041","volume":"16","author":"H Lu","year":"2014","unstructured":"Lu, H. et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat. Cell Biol. 16, 1105\u20131117 (2014).","journal-title":"Nat. Cell Biol."},{"key":"251_CR91","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1158\/0008-5472.CAN-12-4524-T","volume":"73","author":"ZC Hartman","year":"2013","unstructured":"Hartman, Z. C. et al. Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8. Cancer Res. 73, 3470\u20133480 (2013).","journal-title":"Cancer Res."},{"key":"251_CR92","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1172\/JCI39397","volume":"120","author":"C Ginestier","year":"2010","unstructured":"Ginestier, C. et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J. Clin. Invest. 120, 485\u2013497 (2010).","journal-title":"J. Clin. Invest."},{"key":"251_CR93","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1172\/JCI115767","volume":"89","author":"G Strassmann","year":"1992","unstructured":"Strassmann, G., Fong, M., Kenney, J. S. & Jacob, C. O. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J. Clin. Invest. 89, 1681\u20131684 (1992).","journal-title":"J. Clin. Invest."},{"key":"251_CR94","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/bjc.1993.174","volume":"67","author":"Y Ohe","year":"1993","unstructured":"Ohe, Y. et al. Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice. Br. J. Cancer 67, 939\u2013944 (1993).","journal-title":"Br. J. Cancer"},{"key":"251_CR95","doi-asserted-by":"publisher","first-page":"E1863","DOI":"10.3390\/cancers11121863","volume":"11","author":"CS Callaway","year":"2019","unstructured":"Callaway, C. S. et al. IL-8 released from human pancreatic cancer and tumor-associated stromal cells signals through a CXCR2-ERK1\/2 axis to induce muscle atrophy. Cancers 11, E1863 (2019).","journal-title":"Cancers"},{"key":"251_CR96","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820\u2013827 (2005).","journal-title":"Nature"},{"key":"251_CR97","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nrc.2017.6","volume":"17","author":"H Peinado","year":"2017","unstructured":"Peinado, H. et al. Pre-metastatic niches: organ-specific homes for metastases. Nat. Rev. Cancer 17, 302\u2013317 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"251_CR98","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva, B. et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. Cell Biol. 17, 816\u2013826 (2015).","journal-title":"Nat. Cell Biol."},{"key":"251_CR99","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/ncb1507","volume":"8","author":"S Hiratsuka","year":"2006","unstructured":"Hiratsuka, S., Watanabe, A., Aburatani, H. & Maru, Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369\u20131375 (2006).","journal-title":"Nat. Cell Biol."},{"key":"251_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2856","volume":"4","author":"S Hiratsuka","year":"2013","unstructured":"Hiratsuka, S. et al. Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci. Nat. Commun. 4, 1853 (2013).","journal-title":"Nat. Commun."},{"key":"251_CR101","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature07623","volume":"457","author":"S Kim","year":"2009","unstructured":"Kim, S. et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457, 102\u2013106 (2009).","journal-title":"Nature"},{"key":"251_CR102","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41586-019-1004-y","volume":"567","author":"JW Lee","year":"2019","unstructured":"Lee, J. W. et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature 567, 249\u2013252 (2019).","journal-title":"Nature"},{"key":"251_CR103","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/ncb1794","volume":"10","author":"S Hiratsuka","year":"2008","unstructured":"Hiratsuka, S. et al. The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol. 10, 1349\u20131355 (2008).","journal-title":"Nat. Cell Biol."},{"key":"251_CR104","doi-asserted-by":"publisher","first-page":"21248","DOI":"10.1073\/pnas.1015855107","volume":"107","author":"M Kowanetz","year":"2010","unstructured":"Kowanetz, M. et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc. Natl Acad. Sci. USA 107, 21248\u201321255 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"251_CR105","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert, A. W., Pattabiraman, D. R. & Weinberg, R. A. Emerging biological principles of metastasis. Cell 168, 670\u2013691 (2017).","journal-title":"Cell"},{"key":"251_CR106","doi-asserted-by":"publisher","first-page":"a031252","DOI":"10.1101\/cshperspect.a031252","volume":"8","author":"M Esposito","year":"2018","unstructured":"Esposito, M., Guise, T. & Kang, Y. The biology of bone metastasis. Cold Spring Harb. Perspect. Med. 8, a031252 (2018).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"251_CR107","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrc867","volume":"2","author":"GR Mundy","year":"2002","unstructured":"Mundy, G. R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat. Rev. Cancer 2, 584\u2013593 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"251_CR108","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1172\/JCI3523","volume":"103","author":"JJ Yin","year":"1999","unstructured":"Yin, J. J. et al. TGF-\u03b2 signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest. 103, 197\u2013206 (1999).","journal-title":"J. Clin. Invest."},{"key":"251_CR109","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1038\/s41388-019-0736-3","volume":"38","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion. Oncogene 38, 4540\u20134559 (2019).","journal-title":"Oncogene"},{"key":"251_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37425-6","volume":"9","author":"M Kalli","year":"2019","unstructured":"Kalli, M. et al. Solid stress-induced migration is mediated by GDF15 through Akt pathway activation in pancreatic cancer cells. Sci. Rep. 9, 978 (2019).","journal-title":"Sci. Rep."},{"key":"251_CR111","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1158\/0008-5472.CAN-13-2259","volume":"74","author":"F Bruzzese","year":"2014","unstructured":"Bruzzese, F. et al. Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15. Cancer Res. 74, 3408\u20133417 (2014).","journal-title":"Cancer Res."},{"key":"251_CR112","doi-asserted-by":"crossref","first-page":"860","DOI":"10.18632\/oncotarget.6205","volume":"7","author":"C Li","year":"2016","unstructured":"Li, C. et al. GDF15 promotes EMT and metastasis in colorectal cancer. Oncotarget 7, 860\u2013872 (2016).","journal-title":"Oncotarget"},{"key":"251_CR113","first-page":"2642","volume":"9","author":"DA Brown","year":"2003","unstructured":"Brown, D. A. et al. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin. Cancer Res. 9, 2642\u20132650 (2003).","journal-title":"Clin. Cancer Res."},{"key":"251_CR114","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jcsm.12033","volume":"6","author":"L Lerner","year":"2015","unstructured":"Lerner, L. et al. Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients. J. Cachexia Sarcopenia Muscle 6, 317\u2013324 (2015).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"251_CR115","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/SPC.0000000000000384","volume":"12","author":"VW Tsai","year":"2018","unstructured":"Tsai, V. W., Brown, D. A. & Breit, S. N. Targeting the divergent TGF\u03b2 superfamily cytokine MIC-1\/GDF15 for therapy of anorexia\/cachexia syndromes. Curr. Opin. Support. Palliat. Care 12, 404\u2013409 (2018).","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"251_CR116","first-page":"3590","volume":"51","author":"G Zugmaier","year":"1991","unstructured":"Zugmaier, G. et al. Transforming growth factor beta 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res. 51, 3590\u20133594 (1991).","journal-title":"Cancer Res."},{"key":"251_CR117","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ijc.1425","volume":"94","author":"H Iguchi","year":"2001","unstructured":"Iguchi, H., Onuma, E., Sato, K., Sato, K. & Ogata, E. Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen. Int. J. Cancer 94, 24\u201327 (2001).","journal-title":"Int. J. Cancer"},{"key":"251_CR118","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1056\/NEJMcp042806","volume":"352","author":"AF Stewart","year":"2005","unstructured":"Stewart, A. F. Clinical practice. Hypercalcemia associated with cancer. N. Engl. J. Med. 352, 373\u2013379 (2005).","journal-title":"N. Engl. J. Med."},{"key":"251_CR119","doi-asserted-by":"publisher","first-page":"28109","DOI":"10.1074\/jbc.M111013200","volume":"277","author":"C Guillen","year":"2002","unstructured":"Guillen, C., Martinez, P., de Gortazar, A. R., Martinez, M. E. & Esbrit, P. Both N- and C-terminal domains of parathyroid hormone-related protein increase interleukin-6 by nuclear factor-\u03baB activation in osteoblastic cells. J. Biol. Chem. 277, 28109\u201328117 (2002).","journal-title":"J. Biol. Chem."},{"key":"251_CR120","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/jbmr.5650110606","volume":"11","author":"JH Pollock","year":"1996","unstructured":"Pollock, J. H., Blaha, M. J., Lavish, S. A., Stevenson, S. & Greenfield, E. M. In vivo demonstration that parathyroid hormone and parathyroid hormone-related protein stimulate expression by osteoblasts of interleukin-6 and leukemia inhibitory factor. J. Bone Min. Res. 11, 754\u2013759 (1996).","journal-title":"J. Bone Min. Res."},{"key":"251_CR121","doi-asserted-by":"publisher","first-page":"19976","DOI":"10.1074\/jbc.M115.638411","volume":"290","author":"DN Seto","year":"2015","unstructured":"Seto, D. N., Kandarian, S. C. & Jackman, R. W. A key role for leukemia inhibitory factor in C26 cancer cachexia. J. Biol. Chem. 290, 19976\u201319986 (2015).","journal-title":"J. Biol. Chem."},{"key":"251_CR122","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0303-7207(01)00496-8","volume":"180","author":"R Sakai","year":"2001","unstructured":"Sakai, R. & Eto, Y. Involvement of activin in the regulation of bone metabolism. Mol. Cell Endocrinol. 180, 183\u2013188 (2001).","journal-title":"Mol. Cell Endocrinol."},{"key":"251_CR123","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10585-006-9010-5","volume":"23","author":"G Leto","year":"2006","unstructured":"Leto, G. et al. Activin A circulating levels in patients with bone metastasis from breast or prostate cancer. Clin. Exp. Metastasis 23, 117\u2013122 (2006).","journal-title":"Clin. Exp. Metastasis"},{"key":"251_CR124","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1096\/fj.13-245894","volume":"28","author":"JL Chen","year":"2014","unstructured":"Chen, J. L. et al. Elevated expression of activins promotes muscle wasting and cachexia. FASEB J. 28, 1711\u20131723 (2014).","journal-title":"FASEB J."},{"key":"251_CR125","doi-asserted-by":"publisher","first-page":"18117","DOI":"10.1073\/pnas.0505996102","volume":"102","author":"SJ Lee","year":"2005","unstructured":"Lee, S. J. et al. Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc. Natl Acad. Sci. USA 102, 18117\u201318122 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"251_CR126","doi-asserted-by":"publisher","first-page":"8817","DOI":"10.1073\/pnas.91.19.8817","volume":"91","author":"MM Matzuk","year":"1994","unstructured":"Matzuk, M. M. et al. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Natl Acad. Sci. USA 91, 8817\u20138821 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"251_CR127","doi-asserted-by":"publisher","first-page":"12448","DOI":"10.1073\/pnas.1707925114","volume":"114","author":"F Morvan","year":"2017","unstructured":"Morvan, F. et al. Blockade of activin type II receptors with a dual anti-ActRIIA\/IIB antibody is critical to promote maximal skeletal muscle hypertrophy. Proc. Natl Acad. Sci. USA 114, 12448\u201312453 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"251_CR128","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.trecan.2015.07.009","volume":"1","author":"AC Obenauf","year":"2015","unstructured":"Obenauf, A. C. & Massague, J. Surviving at a distance: organ specific metastasis. Trends Cancer 1, 76\u201391 (2015).","journal-title":"Trends Cancer"},{"key":"251_CR129","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3390\/cancers12010003","volume":"12","author":"AR Shakri","year":"2019","unstructured":"Shakri, A. R. et al. Upregulation of ZIP14 and altered zinc homeostasis in muscles in pancreatic cancer cachexia. Cancers 12, E3 (2019).","journal-title":"Cancers"},{"key":"251_CR130","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/jso.2930520311","volume":"52","author":"SK Gupta","year":"1993","unstructured":"Gupta, S. K., Shukla, V. K., Vaidya, M. P., Roy, S. K. & Gupta, S. Serum and tissue trace elements in colorectal cancer. J. Surg. Oncol. 52, 172\u2013175 (1993).","journal-title":"J. Surg. Oncol."},{"key":"251_CR131","first-page":"1943","volume":"48","author":"K Morikawa","year":"1988","unstructured":"Morikawa, K., Walker, S. M., Jessup, J. M. & Fidler, I. J. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res. 48, 1943\u20131948 (1988).","journal-title":"Cancer Res."},{"key":"251_CR132","doi-asserted-by":"publisher","first-page":"djv274","DOI":"10.1093\/jnci\/djv274","volume":"107","author":"YC Tseng","year":"2015","unstructured":"Tseng, Y. C. et al. Preclinical investigation of the novel histone deacetylase inhibitor AR-42 in the treatment of cancer-induced cachexia. J. Natl Cancer Inst. 107, djv274 (2015).","journal-title":"J. Natl Cancer Inst."},{"key":"251_CR133","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nature09515","volume":"467","author":"S Yachida","year":"2010","unstructured":"Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114\u20131117 (2010).","journal-title":"Nature"},{"key":"251_CR134","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cell.2011.11.025","volume":"148","author":"AD Rhim","year":"2012","unstructured":"Rhim, A. D. et al. EMT and dissemination precede pancreatic tumor formation. Cell 148, 349\u2013361 (2012).","journal-title":"Cell"},{"key":"251_CR135","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","volume":"13","author":"Y Husemann","year":"2008","unstructured":"Husemann, Y. et al. Systemic spread is an early step in breast cancer. Cancer Cell 13, 58\u201368 (2008).","journal-title":"Cancer Cell"},{"key":"251_CR136","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.semcdb.2015.10.038","volume":"54","author":"KG Burfeind","year":"2016","unstructured":"Burfeind, K. G., Michaelis, K. A. & Marks, D. L. The central role of hypothalamic inflammation in the acute illness response and cachexia. Semin. Cell Dev. Biol. 54, 42\u201352 (2016).","journal-title":"Semin. Cell Dev. Biol."},{"key":"251_CR137","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1084\/jem.20111020","volume":"208","author":"TP Braun","year":"2011","unstructured":"Braun, T. P. et al. Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis. J. Exp. Med. 208, 2449\u20132463 (2011).","journal-title":"J. Exp. Med."},{"key":"251_CR138","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3181\/00379727-77-18766","volume":"77","author":"BK Anand","year":"1951","unstructured":"Anand, B. K. & Brobeck, J. R. Localization of a \u201cfeeding center\u201d in the hypothalamus of the rat. Proc. Soc. Exp. Biol. Med. 77, 323\u2013324 (1951).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"251_CR139","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5483\/BMBRep.2015.48.4.272","volume":"48","author":"JW Sohn","year":"2015","unstructured":"Sohn, J. W. Network of hypothalamic neurons that control appetite. BMB Rep. 48, 229\u2013233 (2015).","journal-title":"BMB Rep."},{"key":"251_CR140","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1210\/en.2007-0381","volume":"148","author":"ER Ropelle","year":"2007","unstructured":"Ropelle, E. R. et al. A central role for neuronal adenosine 5\u2019-monophosphate-activated protein kinase in cancer-induced anorexia. Endocrinology 148, 5220\u20135229 (2007).","journal-title":"Endocrinology"},{"key":"251_CR141","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/nn.4574","volume":"20","author":"CA Campos","year":"2017","unstructured":"Campos, C. A. et al. Cancer-induced anorexia and malaise are mediated by CGRP neurons in the parabrachial nucleus. Nat. Neurosci. 20, 934\u2013942 (2017).","journal-title":"Nat. Neurosci."},{"key":"251_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-018-0188-4","volume":"9","author":"P Cui","year":"2019","unstructured":"Cui, P. et al. Metabolic derangements of skeletal muscle from a murine model of glioma cachexia. Skelet. Muscle 9, 3 (2019).","journal-title":"Skelet. Muscle"},{"key":"251_CR143","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10585-012-9510-4","volume":"30","author":"AS Berghoff","year":"2013","unstructured":"Berghoff, A. S., Lassmann, H., Preusser, M. & Hoftberger, R. Characterization of the inflammatory response to solid cancer metastases in the human brain. Clin. Exp. Metastasis 30, 69\u201381 (2013).","journal-title":"Clin. Exp. Metastasis"},{"key":"251_CR144","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc.2016.25","volume":"16","author":"PS Steeg","year":"2016","unstructured":"Steeg, P. S. Targeting metastasis. Nat. Rev. Cancer 16, 201\u2013218 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"251_CR145","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon, K. et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 12, 489\u2013495 (2011).","journal-title":"Lancet Oncol."},{"key":"251_CR146","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/SPC.0b013e328331124a","volume":"3","author":"CM Prado","year":"2009","unstructured":"Prado, C. M., Birdsell, L. A. & Baracos, V. E. The emerging role of computerized tomography in assessing cancer cachexia. Curr. Opin. Support. Palliat. Care 3, 269\u2013275 (2009).","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"251_CR147","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1073\/pnas.0604893104","volume":"104","author":"H Amthor","year":"2007","unstructured":"Amthor, H. et al. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc. Natl Acad. Sci. USA 104, 1835\u20131840 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"251_CR148","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel, J. S. et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 17, 519\u2013531 (2016).","journal-title":"Lancet Oncol."},{"key":"251_CR149","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/jcsm.12402","volume":"10","author":"MS Anker","year":"2019","unstructured":"Anker, M. S. et al. Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review. J. Cachexia Sarcopenia Muscle 10, 22\u201334 (2019).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"251_CR150","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/annonc\/mdu086","volume":"25","author":"D Blum","year":"2014","unstructured":"Blum, D. et al. Validation of the consensus-definition for cancer cachexia and evaluation of a classification model\u2013a study based on data from an international multicentre project (EPCRC-CSA). Ann. Oncol. 25, 1635\u20131642 (2014).","journal-title":"Ann. Oncol."},{"key":"251_CR151","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1615\/CritRevOncog.v17.i3.70","volume":"17","author":"A Vigano","year":"2012","unstructured":"Vigano, A., Del Fabbro, E., Bruera, E. & Borod, M. The cachexia clinic: from staging to managing nutritional and functional problems in advanced cancer patients. Crit. Rev. Oncog. 17, 293\u2013303 (2012).","journal-title":"Crit. Rev. Oncog."}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41568-020-0251-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41568-020-0251-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41568-020-0251-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:20:44Z","timestamp":1684621244000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41568-020-0251-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":151,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["251"],"URL":"https:\/\/doi.org\/10.1038\/s41568-020-0251-4","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]},"assertion":[{"value":"27 February 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}